Texas HB4422 prohibits discriminatory practices by health benefit plan issuers, pharmacy benefit managers, and third-party payors against entities.
Texas HB4422 amends the Insurance Code to add a new subchapter prohibiting discriminatory practices by health benefit plan issuers, pharmacy benefit managers, and third-party payors against entities participating in the federal 340B drug discount program. Specifically, the bill prohibits these entities from reimbursing covered entities at lower rates than non-covered entities, imposing different terms on covered entities, or creating restrictions or additional charges for patients choosing to receive drugs from covered entities.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.